Chicago 2014 TFQO: Nikolaos Nikolaou COI#253 EVREV 1: Nikolaos Nikolaou COI#253 EVREV 2: Farzin...

18
Chicago 2014 TFQO: Nikolaos Nikolaou COI#253 EVREV 1: Nikolaos Nikolaou COI#253 EVREV 2: Farzin BeyguiCOI#202 Taskforce: ACS STEMI transfer PCI vs. FL and routine early angio (PICO ID#779)

Transcript of Chicago 2014 TFQO: Nikolaos Nikolaou COI#253 EVREV 1: Nikolaos Nikolaou COI#253 EVREV 2: Farzin...

Page 1: Chicago 2014 TFQO: Nikolaos Nikolaou COI#253 EVREV 1: Nikolaos Nikolaou COI#253 EVREV 2: Farzin BeyguiCOI#202 Taskforce: ACS STEMI transfer PCI vs. FL.

Chicago 2014

TFQO: Nikolaos Nikolaou COI#253EVREV 1: Nikolaos Nikolaou COI#253EVREV 2: Farzin BeyguiCOI#202Taskforce: ACS

STEMI transfer PCI vs. FL and routine early angio

(PICO ID#779)

Page 2: Chicago 2014 TFQO: Nikolaos Nikolaou COI#253 EVREV 1: Nikolaos Nikolaou COI#253 EVREV 2: Farzin BeyguiCOI#202 Taskforce: ACS STEMI transfer PCI vs. FL.

COI Disclosure (SPECIFIC to this systematic review)

Nikolaos Nikolaou COI#253Commercial/industry: NonePotential intellectual conflicts: None

Farzin Beygui#202Commercial/industry: NonePotential intellectual conflicts: None

Page 3: Chicago 2014 TFQO: Nikolaos Nikolaou COI#253 EVREV 1: Nikolaos Nikolaou COI#253 EVREV 2: Farzin BeyguiCOI#202 Taskforce: ACS STEMI transfer PCI vs. FL.

2010 Treatment Recommendation

2010: NO TREATMENT RECOMMENDATION

Page 4: Chicago 2014 TFQO: Nikolaos Nikolaou COI#253 EVREV 1: Nikolaos Nikolaou COI#253 EVREV 2: Farzin BeyguiCOI#202 Taskforce: ACS STEMI transfer PCI vs. FL.

C2015 PICO

Population: Adult patients with STEMI in the ED (of a non-PCI capable hospital) Intervention: immediate inhospital fibrinolysis and routine transfer for angiography at 3-6 hours (or up to 24 hours)Comparison: transfer for PPCIOutcomes: (short term mortality: 9, reinfarction: 5, stroke: 6, major bleeding: 6.)

Page 5: Chicago 2014 TFQO: Nikolaos Nikolaou COI#253 EVREV 1: Nikolaos Nikolaou COI#253 EVREV 2: Farzin BeyguiCOI#202 Taskforce: ACS STEMI transfer PCI vs. FL.

Inclusion/Exclusion& Articles Found

List Inclusions/ExclusionsStudies in which all or the majority of STEMI patients had:

• Recruitment in the ED of a non PCI hospital• FL in the emergency department • Angiography within >3and up to 24 h from FL.

Exclusion: Studies in which all or the majority of STEMI patients had:

• FL in the pre-hospital setting• angiography within 3 h from FL• half dose FL, or half dose FL+GPIIb-IIIa antgonists

Page 6: Chicago 2014 TFQO: Nikolaos Nikolaou COI#253 EVREV 1: Nikolaos Nikolaou COI#253 EVREV 2: Farzin BeyguiCOI#202 Taskforce: ACS STEMI transfer PCI vs. FL.

Number of Articles initially identified: 706and number Finally Included in Evidence Profile tables

RCTs:2non-RCTs: 1

Page 7: Chicago 2014 TFQO: Nikolaos Nikolaou COI#253 EVREV 1: Nikolaos Nikolaou COI#253 EVREV 2: Farzin BeyguiCOI#202 Taskforce: ACS STEMI transfer PCI vs. FL.

NN BF

Page 8: Chicago 2014 TFQO: Nikolaos Nikolaou COI#253 EVREV 1: Nikolaos Nikolaou COI#253 EVREV 2: Farzin BeyguiCOI#202 Taskforce: ACS STEMI transfer PCI vs. FL.
Page 9: Chicago 2014 TFQO: Nikolaos Nikolaou COI#253 EVREV 1: Nikolaos Nikolaou COI#253 EVREV 2: Farzin BeyguiCOI#202 Taskforce: ACS STEMI transfer PCI vs. FL.
Page 10: Chicago 2014 TFQO: Nikolaos Nikolaou COI#253 EVREV 1: Nikolaos Nikolaou COI#253 EVREV 2: Farzin BeyguiCOI#202 Taskforce: ACS STEMI transfer PCI vs. FL.

For the critical outcome of “30 day mortality” we have identified low quality evidence -downgraded for imprecision and indirectness -from 2 RCTs enrolling 337 patients with STEMI showing no difference (OR 0.84 95% CI 0.24 – 2.98) For the critical outcome of “30 day mortality” we have also identified 1 nonRCT of very low quality evidence-downgraded for risk of bias and imprecision, showing no difference (OR 0.86 95% CI 0.48 – 1.55)For the critical outcome of ICH we have identified low quality evidence, downgraded for imprecision and indirectness, from 2 RCTs enrolling 337 patients with STEMI showing no difference (OR 3.14 95%CI: 0.13-78.08). 

Page 11: Chicago 2014 TFQO: Nikolaos Nikolaou COI#253 EVREV 1: Nikolaos Nikolaou COI#253 EVREV 2: Farzin BeyguiCOI#202 Taskforce: ACS STEMI transfer PCI vs. FL.

For the important outcome of  “Reinfarction”, we have identified low quality evidence -downgraded for imprecision and indirectness -from the same 2 RCTs enrolling 337 patients with STEMI showing no difference (OR 2.11, 95% CI: 0.51 – 8.64). For the important outcome of “Reinfarction” we also identified 1 nonRCT of very low quality evidence-downgraded for risk of bias and imprecision-showing no difference (OR 2.2 95% CI 0.73 – 6.61)  For the important outcome of “Stroke” we have identified low quality evidence -downgraded for imprecision and indirectness -from the same 2 RCTs enrolling 416 patients with STEMI showing no difference (OR 0.96 95% CI: 0.06 – 15.58). For the important outcome of “Stroke” we also identified 1 non RCT of very low quality evidence-downgraded for risk of bias and imprecision showing no difference 1.52 95% CI 0.41 – 5.67) For the important outcome of  “Major bleeding” we have identified low quality evidence -downgraded for imprecision and indirectness -from the same 2 RCTs enrolling 337 patients with STEMI showing no difference (OR 1.33, 95% CI: 0.32 – 5.47). For the important outcome of “major bleeding” we also identified 1 non RCT of very low quality evidence-downgraded for risk of bias and imprecision (OR 0.65 95% CI 0.26 – 1.63)

Page 12: Chicago 2014 TFQO: Nikolaos Nikolaou COI#253 EVREV 1: Nikolaos Nikolaou COI#253 EVREV 2: Farzin BeyguiCOI#202 Taskforce: ACS STEMI transfer PCI vs. FL.

Draft Treatment Recommendations

For patients presenting in the ED of a non-PCI hospital we suggest for fibrinolytic therapy with routine transfer for angiography as an equivalent to PPCI.In making this recommendation we place a higher value on not allocating resource to an unproven intervention over any yet to be proven benefit for critical or important outcomesPatients with contraindications to fibrinolysis were excluded.This recommendation is particularly valuable in case patients cannot be transferred to a PPCI capable center in a timely manner.

Page 13: Chicago 2014 TFQO: Nikolaos Nikolaou COI#253 EVREV 1: Nikolaos Nikolaou COI#253 EVREV 2: Farzin BeyguiCOI#202 Taskforce: ACS STEMI transfer PCI vs. FL.

Knowledge Gaps *DO NOT USE FOR PLENARY* - BREAKOUT ONLY

Other specific worksheets that would be helpful

Patient subgroups (cardiogenic shock)Interventions (pharmakoinvasive approach-pre-hospital fibrinolysis)Outcomes:

Specific research required: same topic

Page 14: Chicago 2014 TFQO: Nikolaos Nikolaou COI#253 EVREV 1: Nikolaos Nikolaou COI#253 EVREV 2: Farzin BeyguiCOI#202 Taskforce: ACS STEMI transfer PCI vs. FL.

30 day mortality-Inconsistency

Page 15: Chicago 2014 TFQO: Nikolaos Nikolaou COI#253 EVREV 1: Nikolaos Nikolaou COI#253 EVREV 2: Farzin BeyguiCOI#202 Taskforce: ACS STEMI transfer PCI vs. FL.

Inconsistency-reinfarction

Page 16: Chicago 2014 TFQO: Nikolaos Nikolaou COI#253 EVREV 1: Nikolaos Nikolaou COI#253 EVREV 2: Farzin BeyguiCOI#202 Taskforce: ACS STEMI transfer PCI vs. FL.

Inconsistency-Stroke

Page 17: Chicago 2014 TFQO: Nikolaos Nikolaou COI#253 EVREV 1: Nikolaos Nikolaou COI#253 EVREV 2: Farzin BeyguiCOI#202 Taskforce: ACS STEMI transfer PCI vs. FL.

Inconsistency-Major bleeding

Page 18: Chicago 2014 TFQO: Nikolaos Nikolaou COI#253 EVREV 1: Nikolaos Nikolaou COI#253 EVREV 2: Farzin BeyguiCOI#202 Taskforce: ACS STEMI transfer PCI vs. FL.

Inconsistency-ICH